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Abstract
Background: Recent studies have reported the roles of Hyaluronic acid (HA) chains of diverse length in wound
repair, especially considering the simultaneous occurrence in vivo of both high- (H-HA) and low-molecular weight
(L-HA) hyaluronan at an injury site. It has been shown that HA fragments (5 ≤MW ≤ 20 kDa) usually trigger an
inflammatory response that, on one hand, is the first signal in the activation of a repair mechanism but on the
other, when it’s overexpressed, it may promote unwanted side effects. The present experimental research has
aimed to investigate H-HA, L-HA and of a newly developed complex of the two (H-HA/L-HA) for stability (e.g.
hyaluronidases digestion), for their ability to promote wound healing of human keratinocytes in vitro and for their
effect on cellular biomarker expression trends.
Results: Time-lapse video microscopy studies proved that the diverse HA was capable of restoring the monolayer
integrity of HaCat. The H-HA/L-HA complex (0.1 and 1%w/v) proved faster in regeneration also in co-culture
scratch test where wound closure was achieved in half the time of H-HA stimulated cells and 2.5-fold faster than
the control. Gene expression was evaluated for transformation growth factor beta 1 (TGF-β1) proving that L-HA
alone increased its expression at 4 h followed by restoration of similar trends for all the stimuli. Depending on
the diverse stimulation (H-HA, L-HA or the complex), metalloproteinases (MMP-2, -9, -13) were also modulated differently.
Furthermore, type I collagen expression and production were evaluated. Compared to the others, persistence of a
significant higher expression level at 24 h for the H-HA/L-HA complex was found.
Conclusions: The outcomes of this research showed that, both at high and low concentrations, hybrid complexes
proved to perform better than HA alone thus suggesting their potential as medical devices in aesthetic and
regenerative medicine.
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Background
Frequently called hyaluronan (HA), Na-Hyaluronate, has
been extensively used for biomedical applications, in-
cluding osteoarthritis treatment, tissue augmentation
and ocular surgery, and as scaffold for tissue engineering
[1]. In particular, it has been well established that HA is
associated with tissue repair [2–5]. Although this macro-
molecule participates in many different biological pro-
cesses during regeneration, detailed action mechanisms
have still not been thoroughly unravelled.
Being involved in cell proliferation and migration, HA
also provides important functions in wound healing: its
contribution in these processes is associated with the
hydrophilic and highly osmotic features of the macro-
molecule, which allow for the control of associated in-
flammatory processes and skin hydration. In fact, HA
creates an environment that loosens cell anchorage to
the extracellular matrix (ECM), facilitating cell migration
and division [6].
HA produces different effects on the basis of its mo-
lecular weight [7]. In the earliest phase of wound healing
(WH) in vivo, there is a sharp increase in HA right after
injury: in particular, high molecular weight HA (H-HA)
accumulates and binds fibrinogen that is fundamental for
clot formation. Furthermore, an initial large amount of H-
HA opens up tissue spaces, facilitating polymorpho-
nuclear leukocyte (PMN) access to the wound site for
removal of dead tissue, debris, and bacteria. Thereafter, in
the inflammatory stage, there is an accumulation of low
molecular weight HA (L-HA), which is generated from
degradation of H-HA, inducing cytokine response and
stimulating angiogenesis [8]. Many reports have studied
the effects of exogenous H-HA or L-HA to obtain in-
formation on the role of HA in wound healing and to
design innovative pharmaceutical/cosmeceutical formu-
lations based on HA size [9–14].
A potential functional significance in the turnover of
HA fragments during wound repair has also been sug-
gested in vitro [15–17]. For example, the importance of
L-HA (35–280 kDa) in propagating an inflammatory
response (through activation of macrophages and induc-
tion of chemokines) has been well described by McKee
and co-authors [18]. Similarly, other studies have shown
that low- and intermediate-molecular weight HA (20–
450 kDa) stimulated gene expression in endothelial and
epithelial cells, macrophages and eosinophils [19–21].
Cutaneous wound healing consists in re-epithelization,
which involves migration and proliferation of keratino-
cytes to cover the dermal surface. For this reason, many
studies have used systems that simplify the complex
mechanism of repair, such as the scratch-wound in vitro
assay [13, 22, 23]. In addition, extensive molecular stud-
ies have been conducted to assess gene expression and
signal molecules related to the re-epithelization process.
It is known that the healing of human skin wounds
requires a complex interplay between cells and ECM. A
number of events converges on the process and are con-
trolled by: growth factors including transforming growth
factor β1 (TGF-β1) and metalloproteases (MMPs) [24].
TGF-β1 is one of the inflammatory process trigger markers
and has also been recognized as a key regulator of type I
collagen expression [25]. MMPs elicit a pro-inflammatory
response for cellular recruitment and degradation of ECM
components, promoting migration during wound closure
and remodelling. Therefore, MMPs are up-regulated dur-
ing wound healing in epidermal cells, dermal cells, fibro-
blasts and blood cells in mammals [26].
In this context, the aim of this study was to compare
activity of high and low molecular weight HA and hy-
brid H-HA/L-HA complex in view of their potential
application in medical devices for tissue regeneration.
Experimental
Materials
High- (H-HA; MW 1400 ± kDa, Mw/Mn = 1.5, Intrinsic
viscosity =21.5 dl/g) and low-molecular weight hyaluronic
acid (L-HA: Mw = 90 ± 5 kDa, Mw/Mn= 1.7 ± 0.07 Intrin-
sic viscosity =2.4 dl/g) were kindly provided by Altergon
s.r.l., Italy. Altergon HA is a fermentative HA from
Streptococcus equi ssp. equi, at pharmaceutical grade (e.g.
purity >95 %, water content < 10 %, EU/mg < 0.05). This
ensured that the products are controlled according to the
pharmacopeia. Briefly in collaboration with Altergon,
LHA 90 kDa was obtained through heterogeneous hydro-
lytic reaction in acidic conditions. The hydrodynamic
characterization was performed using the SEC-TDA (Size
Exclusion Chromatography-Triple Detector Array) equip-
ment by Viscotek (Lab Service Analytica, Italy).
The H-HA/L-HA complex (1:1 weight ratio) was pro-
duced in our laboratory following the procedure described
in patent application WO2011EP65633 [27], which was
modified to obtain solutions (32 g/l) suitable for use in cell
cultures (i.e., use of a physiological buffer solution, PBS).
For all samples, pH and osmolality were measured in
order to perform experiments in physiological conditions
(i.e., pH 7.0–7.4; osmolality 300 mOsm). Endotoxin con-
centration (EU/mg) was evaluated with the Limulus test,
and solutions were used only when the titer as <1 EU/mg.
All solutions were sterilized in an autoclave at 1 bar for
12 min at 120 °C.
Bovine testicular hyaluronidase, BTH (EC 3.2.1.35), es-
sentially salt free lyophilized powder with a specific ac-
tivity of 1160U/mg was purchased from Sigma-Aldrich
(Milan, Italy) (cat. N. H3884, lot. N. 057K7014).
HaCaT cells (Istituto Zooprofilattico, Brescia, Italy), a
spontaneously transformed non-tumorigenic human kera-
tinocyte cell line and human dermal fibroblast (HDF), a
generous gift of Prof Caraglia, were cultured in Dulbecco’s
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Modified Eagle Medium (DMEM) supplemented with 10 %
(v/v) heat inactivated fetal bovine serum (FBS), 100 U/mL
penicillin and 100 μg/ml streptomycin. All materials were
purchased from Flow Laboratories (Milan, Italy). The cells
were grown on tissue culture plates (Corning Incorporated,
New York, USA), using an incubator with a humidified
atmosphere (95 % air/5%CO2 v/v) at 37 °C. Collagen was
purchased from Sigma, Aldrich (Milan, Italy).
Methods
Dynamic viscosity measurements of HA gels
The H-HA and H-HA/L-HA (1:1 weight ratio) solutions
were prepared to final concentrations of 0.1 and 1 % w/v
in DMEM–1 % FBS in order to have the same conditions
used for the time-lapse experiments described in the
successive section. In particular, 0.05, 0.5, 0.1 and
1 % w/v H-HA were obtained from stock solutions of 0.1,
1, 0.2 and 2 % w/v in PBS buffer, successively sterilized in
autoclave and, respectively diluted 1:1 with DMEM 2 %
FBS. Analogously, 0.1 and 1 % w/v H-HA/L-HA complex
gels were obtained from a 32 g/l stock solution sterile syr-
inge (used as medical device) and opportunely diluted
with the medium supplemented with final FBS 1%v/v. The
dynamic viscosity (η0) of H-HA and H-HA/L-HA com-
plex at the different concentrations was measured at 37 °C
with a Paar–Physica oscillatory rheometer MCR 301
(Anton Paar, Germany) equipped with a coaxial cylinder
cell. The η of each sample was measured in function of
the shear rate (ranging from 0.001 to 300 s−1), the curves
obtained evaluated and the value of dynamic viscosity (η0)
chosen in the plateau of Newtonian behaviour.
H-HA, L-HA and H-HA/L-HA degradation in the presence
of BTH
The enzymatic degradation was carried as described by
La Gatta et collaborators [28].
Briefly all the samples suspended at 0.4 % w/w in PBS
were prepared and incubated in the presence of final
concentration of BTH 0.5 U/ml at 37 °C in a thermo-
mixer (Eppendorf, USA) under stirring (300 rpm). At in-
creasing incubation times (1,2,4,6,8,24 h), samples were
withdrawn from the thermomixer, boiled for 10 min to
inactivate the enzyme and then stored at -20 °C until
characterization. The chromatographic analyses of HA
fragments produced during degradation were performed
using the SEC-TDA equipment (on line laser light scat-
tering, refractometry and viscosimetry) by Viscotek (Lab
Service Analytica, Italy) [28]. Concerning our purposes,
this analysis allowed us, to derive beside data such as Mw,
Mn and polydispersity index, the fraction of samples with
MW< 200 KDa, and the variation of this fraction during
degradation was used as stability index respect to enzym-
atic hydrolysis.
In vitro scratch-wound healing assay: cell culture and
stimuli preparation
12-well tissue culture plates were collagen-coated with
100 μl of collagen type I (0.1 mg/ml in acetic acid) for
2 h before rinsing with complete medium. HaCat cells
were seeded at a density of about 1.8 × 105 cells/well
(4 × 104cells/cm2) in complete medium. Complete con-
fluence was obtained after 2 days at 37 °C and 5 % CO2
(v/v). These standardized conditions were previously
assessed on the basis of the growth curve for HaCaT cells
(data not shown). Alternatively, in co-culture experiment,
each 12-well was seeded with cells (HaCaT e HDF con-
taining equal number of cells: 2.2 × 104 cell/cm2). Scratch
wounds were created mechanically with a sterile pipette
tip (Ø = 0.1 mm). We were careful to produce uniformly
sized wounds of approximately 0.5–0.9 mm in width.
Detached cells and debris were washed away with PBS
solution.
To test the effect of HA gels on the rate of wound clos-
ure, the scratched monolayers were incubated with
0.1 % w/v H-HA, L-HA and H-HA/L-HA in DMEM
1%FBS. Fresh serum-supplemented medium (1 % v/v FBS)
was used as a control. The conditioned media were pre-
pared as follows. Solutions of 1 % w/w H-HA/L-HA com-
plex, H-HA or L-HA in PBS were prepared by diluting
the stock solution (32 g/l in PBS) or directly dissolving the
H-HA and L-HA powders. Solutions were then oppor-
tunely diluted in DMEM/FBS to have the correct final
serum concentration established for the assay (1 % v/v).
PBS buffer was used, instead of HA solution in PBS, for
the control. In addition, the H-HA/L-HA complex was
tested also at 1 % w/v by directly diluting the stock so-
lution in the medium. Osmolality of all solutions was
measured with an osmometer (Micro-osmometer auto-
matic type 15Loser).
Time-lapse video microscopy station: experimental set up
The ‘wound closure’ phenomenon was monitored for
72–96 h using a time-lapse video microscopy (TLVM),
to observe and evaluate cell behaviour (adhesion, prolif-
eration, differentiation and motility) (Okolab, Italy). The
station is based on an inverted optical microscope (Zeiss
Axiovert 200, Germany) equipped with a CCD–gray-scale
camera (ORCA ER, Hamamatsu Photonics, Hamamatsu
City, Japan), a microscope stage incubator (CO2, T and air
control) that accommodates different wells, a thermostatic
bath (LAUDA, Eco Line RE 204), and a remotely con-
trolled motor that permits micrometric movements and
the repositioning of the stage incubator along x, y and z
cyclically over time. The CO2 microscope stage incubator
maintains all the required environmental conditions for
cell cultures (temperature and atmosphere were kept at
37 °C and 5 % CO2 in air, respectively). The instrument
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was controlled by the custom-tailored software OKO-
Vision 4.3, composed of OKO-Vision Time Lapse and
OKO-Vision Imaging. The former module is used to set
the parameters of time-lapse experiments and to run the
experiment by controlling the operations of the motorized
stages; the latter is used to review the experiment by dis-
playing the recorded images in different formats (panels
and movies) and by quantitative analysis of wound heal-
ing. Measurements of wound closure was calculated as
[(Area t0 −Area t)/Area t0] × 100 by the software. For im-
ages that were not clear the threshold was manually modi-
fied in order to better delineate the lesion area. Data
generated by the software was exported in a common
excel file and used to obtain the reduction in wound area
(in squares micrometres) at each time-point. The repar-
ation rate was then calculated as (Areat1 −Area t2/t2 − t1).
Moreover, the fields of view selected and used to build up
the overall averaged curves all had a similar scratch width,
ranging from 0.7 to 0.9 mm, corresponding to a lesion
area of 16–20 mm2.
The statistical significance of the experiment was en-
sured by the possibility to visualize contemporarily several
fields of view (up to 24) of the same sample (depending on
the delay time chosen by the operator) in the stage incuba-
tor. In our particular case, we collected phase-contrast
images of wound margins every 30–60 min (delay time)
throughout the experiment, until either healing closure
was complete or no longer progressing. Furthermore, a
single field of view (~10 × 105 μm2) represented 5 % of the
total scratch area (~20 × 106 μm2) of each well. Because we
captured at least five field-views in three repetitions per
well, this ensured that we analysed 25–30 % of the scratch
in each specific well. Triplicates were performed for each
scratch assay.
Real time PCR
To elucidate the mechanisms of wound closure pro-
moted by HA, total RNA was extracted from control
and stimulated HaCaT cells at different time-points. Spe-
cifically, after the insult (at least three scratches/well,
corresponding to 30–40 % of the well area) and treat-
ments, the cells were homogenized at different interval
times (4, 10, 16 and 24 h) by TRIzol® (Invitrogen, Milan,
Italy), and total RNA extracted according to the manufac-
turer’s instructions. The suspension, which was centri-
fuged and precipitated by the method mentioned above,
was then re-suspended in nuclease-free water. The con-
centration of the extracted RNA was determined with a
Nanodrop spectrophotometer (Celbio, Milan, Italy), and
qualitative analysis of the RNA carried out through with
1 % agarose-gel (w/v) electrophoresis. For cDNA synthe-
sis, performed with the Reverse Transcription System Kit
(Promega, Milan, Italy), 1 μg of DNase-digested total RNA
was used (DNA-free kit; Ambion-Applied Biosystems).
Quantitative RT-PCR was obtained with the iQ™ SYBR®
Green Supermix (Bio-Rad Laboratories s.r.l., Milan, Italy)
to analyse the expression of TGF-β1, type I collagen,
MMP-2, MMP-9 and MMP-13. BLAST query was used
for the specificity analysis of each qRT-PCR primer pair
and corresponding sequences designed by Beacon De-
signer™ software. The primer sequences and amplification
protocol are given in Table 1. The final melting curve was
performed from 55 to 95 °C. All reactions were carried
out in triplicate, and the expression of specific mRNA
relative to the control was determined after normalization
with respect to the HPRT housekeeping gene, used as in-
ternal control [29]. The fold change in test mRNA expres-
sion was calculated by considering the efficiency of each
primer pair (between 80 % and 110 %), and by using the
comparative threshold method (2ΔΔCt) (ΔΔCt = difference
of ΔCt between treated cells and non-treated cells used as
controls). The results were expressed as normalized fold
expression, calculated by the ratio of crossing points of
amplification curves of several genes and internal stand-
ard, using Bio-Rad iQ™5 software (Bio- Rad Laboratories
s.r.l., Milan, Italy).
Gelatinase assay (MMPs -2 and -9)
In order to evaluate the presence of MMPs (-2 and -9)
in the medium with and without the stimuli, an enzymatic
assay was performed using gelatin as substrate.
A aqueous solution of commercial gelatin (Gelatin
NITTA) 10 g/l was prepared; 100 μl of 24 h incubation cell
medium deriving from a scratched monolayer, was added
to 900 μl of gelatin substrate solution. The samples were
untreated (CTR) and treated with H-HA 0.1 %, L-HA
0.1 % and H-HA/L-HA 0.1 % and 1 % respectively. Also a
negative control consisting of the gelatin alone was incu-
bated. The assay was performed at 37 °C under stirring;
after 6 h the reaction was stopped by boiling the solution
at 100 °C for 10′. The gelatin degradation was evaluated by
HPLC-SEC analyses (UHPLC Dionex Ultimate 3000; Ther-
mofisher), equipped with a UV-VIS detector (from 190 to
600 nm wavelength range). Runs were executed in isocratic
mode on a Tosoh G2000WXL (7,8 × 300 mm, 5um) col-
umn and coupled to a precolumn Tosoh TSK Gel with an
operating buffer containing NaCl 100 mM, filtered through
a 0.22 μm membrane. Separations were performed at
20 °C, applying a flow of 0.5 ml/min for 40 min. The ana-
lysts were detected over the UV spectrum at 280 nm. Peak
areas were evaluated through the Thermofisher Chro-
meleon Software. A gelatin standard curve (R2 = 0.9991)
with five points (range 0.5–16 g/l) were used for quali-
quantitative analyses.
Gel zymography to evaluate activity of MMPs
Gelatin zymography was performed as follows: 10 % SDS-
polyacrylamide separating gel with 0.2 mg/ml of gelatin
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(30 % bis-acrylamide, 1.5 M Tris-HCL pH 8.8, 10 % w/v
ammonium persulfate, 0.04 % v/v TEMED, 10 % v/v SDS
and distilled water to reach final volume) and 5 % SDS-
polyacrylamide staking gel (30 % v/v bisacrylamide, 1 M
tris-HCL pH 6.8, 10%w/v ammonium persulfate, 0.1 % v/v
TEMED, 10 % v/v SDS and distilled water to reach final
volume) was prepared. The gel was loaded with superna-
tants (20 μL) in non-reducing buffer (0.5 M Tris–HCl
pH 6.8, 10 % v/v glycerol, 4 % v/v SDS, and 0.05 % w/v
bromophenol blue) and the electrophoresis was carried at
4 °C at 90 V for approximately 2.5 h. Gels were washed 2
times in 2.5%v/v Triton-x 100 for 15 min, incubated on in-
cubation buffer (Tris–HCl 50 mM, CaCl2 10 mM, NaCl
50 mM, pH 7.6) for 16–18 h at 37 °C, stained by 1 % v/v
Coomassie brilliant blue R-250 solution for 10 min under
gentle shaking and then destained with 25 % v/v ethanol
and 8 % v/v acetic acid solution. The gelatinase activity of
each collagenase should correspond to a clear band
against the blue background of stained gel.
Protein extraction and western blot analysis
For protein extraction and Western blot analysis, HaCaT
cells were lysed in a lysis buffer (Tris-HCl 10 mM, NaCl
150 mM, EDTA 2 mM, EGTA 2 mM, Triton X-100 4 %;
Protease Inhibitor Cocktail (Sigma Aldrich, Milan, Italy))
16 h after the scratch and treatments. Protein concentra-
tions were determined with the Bradford method [30].
The samples were loaded, electrophorized on a 8 % SDS–
polyacrylamide gel and electroblotted onto a nitrocellulose
membrane. The membrane was blocked in 5 % milk, 1 %
Tris-buffered saline and 0.05 % Tween-20. Primary anti-
body to detect MMP-13 (Santa Cruz Biotechnology Santa
Cruz, CA, USA) was used according to the manufacturer’s
instructions at a 1:100 dilution. Immunoreactive signals
were detected with a horseradish peroxidase-conjugated
secondary antibody (1:4000) and reacted with the ECL
system (Chemicon-Millipore, Temecula, CA, USA). Pro-
tein levels were normalized with respect to the signal ob-
tained with anti-α-tubulin monoclonal antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA; 1:1000). Semi-
quantitative analysis of protein levels was obtained with
the Gel Doc 2000 UV System and the Gel Doc EZ Imager,
using quantity one software (Bio-Rad Laboratories s.r.l.,
Milan, Italy).
Immunohistochemical analysis
Immunohistochemistry for type I collagen (Abcam,
Cambridge, UK) was performed on scratched HaCaT cells
in 12-well plates fixed with 4 % paraformaldehyde for
10 min at 4 °C and rinsed in PBS. For staining, the DAKO
Cytomation En Vision +HRP kit AEC (DAKO, Milan,
Italy) was used according to the manufacturer’s instruc-
tions. The type I collagen antibody was diluted 1:50 in
PBS. Cells were observed using an inverted light micro-
scope (Axovision zeiss 200). For Type I collagen quantifi-
cation, TIFF images were analyzed with ImageJ software.
Statistical analysis
The above described experiments were performed in du-
plicate or triplicate. Student t-test was used for statistical
evaluation. The results were considered significant when
p value was lower than. 0.05.
Results
Dynamic viscosity
The Dynamic viscosity measurements reported in Table 2
are represented as values extrapolated from the curves
Table 1 Primers sequence used for qRT-PCR analysis
Gene Forward primer Reverse primer Thermal Cycles
Transforming growth factor,
beta 1 (TGFβ-1)
5′TgCggCAgCTgTACATTgA ′3 5′TggTTgTACAgggCCAggA′3 95 °C 10 s, 55 °C 30 s, 72 °C 3 min, 40 cycles
Collagen, type I, alpha 1
(COL1A1)
5′CAgCCgCTTCACCTACAg C′3 5′TTTTgTATTCAATCACTgTCTTgCC′3 94 °C 1 min, 56 °C 2 min, 72 °C 3 min, 40 cycles
Matrix metallopeptidase 2
(MMP-2)
5′gCCgCCTTTAACTggAgCAA′3 5′TTCCAggCATCTgCgATgAg′3 95 °C 10 s, 60 °C 30 s, 72 °C 3 min, 40 cycles
Matrix metallopeptidase 9
(MMP-9)





5′CTggCATgACgCgAACAATA′3 95 °C 10 s, 55 °C 30 s, 72 °C 3 min, 40 cycles
Table 2 Dynamic viscosity (η0) of H-HA and H-HA/L-HA at 0.05,
0.1,0.5 and 1 % w/v calculated with a oscillatory rheometer,
extrapolated in a shear rate ranging from 1 to 10 s−1, in the
Newtonian range plateau
Samples (w/v) in DMEM medium supplemented
with 1 % FBS
Dynamic viscosity (η)
(mPa·s)
H-HA 0.05 % 1.73 ± 0.05
H-HA 0.1 % 2.55 ± 0.07
H-HA 0.5 % 55.2 ± 1.20
H-HA 1 % 378 ± 3.00
H-HA/L-HA COMPLEX 0.1 % 1.65 ± 0.04
H-HA/L-HA COMPLEX 1 % 18.0 ± 1.00
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in the Newtonian plateau range (η0). Since it is known
that the dynamic viscosity value of the stimuli is mainly
ascribable to the H-HA fraction in the complex, we ac-
complished rheological measurements of H-HA 0.5%w/v
and 0.05%w/v solutions. The highest value (378 mPa·s,
Table 2) of η0 was found for H-HA 1 % w/v. The sam-
ples containing half this concentration reported a 7-fold
lower η0 (55 mPa·s), whilst the complex formation with
a global concentration of 1 % w/v (i.e. equal amount of
the H-HA and L-HA) caused a η0 reduction of 3-fold
and 21-fold (with respect to the H-HA 0.5%w/v and
1%w/v). These outstanding differences in rheological be-
haviour presumably could influence the friction experi-
enced by cells during migration towards wound closure.
The η0 values for the stimuli at 0.1 and 0.05 % w/v were
lower and more comparable thus proving that the com-
bination of high and low molecular weight at reduced
concentrations has minor influence on fluido-dynamic
and thus on motility.
Stability of H-HA, L-HA and H-HA/L-HA in the presence
of BTH
Enzymatic digestion of H-HA/L-HA complexes with re-
spect to those of H-HA or L-HA alone was studied to
evaluate resistance (or stability) eventually conferred by
the complex formation. The results confirmed that L-HA
was not attacked by BTH while there are appreciable dif-
ferences in the enzymatic depolymerisation of HA alone
when compared to the H-HA fraction in the complex
[31]. As described in methods section, hydrolyses were
monitored by SEC-TDA analysis. In particular, in the first
2 h of incubation, the high MW reduction percentage
(calculated as [(Mwt0-Mwt)/ Mwt0.] × 100), reached 44 %
for H-HA alone and only 11 % for the complex (data
not shown). Moreover, a peculiar software application of
the Viscotek chromatographer allowed for the measure-
ment of the H-HA fraction with MW> 1MDa and con-
temporarily the L-HA fraction with Mw inferior to
200 kDa (%L-HA < 200 kDa) on samples withdrawn during
BTH incubation. After 24 h, the data showed that the H-
HA fraction with MW> 1MDa decreased by 50 % in the
pure H-HA solutions while only 6.25 % reduction was
found for the H-HA/L-HA complex. Contemporarily,
L-HA% < 200 kDa proved relatively invariable (1.44 % of
reduction) for H-HA/L-HA, while in the pure H-HA sam-
ples the low molecular weight fraction increased by 128 %
(Table 3).
In vitro scratch-wound healing assay
We investigated the effect of H-HA, L-HA and the
H-HA/L-HA complex on wound closure in HaCaT cell
monolayers. The results were reported in Fig. 1. It is evi-
dent that the scratch closure occurred at a faster rate in
the presence of the diverse HA compared to the one in
the control. Among the different HA gels analysed, the
0.1 % w/v H-HA/L-HA complex acted faster than either
H-HA alone or L-HA alone, which were similar in their
scratch closure rate. We derived the percent wound
closure curves by averaging at least five fields from each
triplicate independent experiment (Fig. 2a). At 20 h of
culture, wound closure in the control was less than
75 %, while it had already reached 85–100 % in the
presence of HA. Total wound closure occurred at 26 ± 2 h
in the presence of 0.1 % H-HA or 0.1 % L-HA, and at 18 ±
1 h with 0.1 % H-HA/L-HA, suggesting a synergistic effect
between the HA forms (Fig. 1a). Considering the rate of
closure, HA and control cultures were mainly similar at
0–6 h, whereas better short-term (6–12 h) actions were
evident for all the HA treatments, especially when the
0.1 % H-HA/L-HA complex was used (Fig. 1b).
Higher concentration of H-HA/L-HA complex (i.e.,
1 % w/v) was then tested to verify whether it was pos-
sible to further hasten wound repair. For this, a wider
scratch (>1 mm) was manually inferred to the cell
monolayer. Wound closure was quicker by almost 5 h
with 1 % H-HA/L-HA (Fig. 2a). The 11-fold higher vis-
cosity of the 1 % H-HA/L-HA complex with respect to
the 0.1 % one (Table 2) initially hampered cell migration
but later on, in the repair process, the mixture probably
became less viscous due to degradation of H-HA, and
enhanced reparation (Fig. 2b).
Concerning the co-culture experiments, Fig. 3a showed
representative images of HaCat and HDF cell migrating to
repair the scratch in the control and in the presence of
stimuli; we confirmed once more, better and faster repara-
tory effect of complexes respect to the single HA samples
at both concentrations: 0.1 e 1 % w/w. Particularly, in the
Fig. 3b, it is evident that the wound closure (%) in pres-
ence of H-HA/L-HA was 1.5 and 1.4 fold higher with re-
spect to the control, while for HHA and LHA it
improved ≈ 1.2 fold.
Gene expression analysis
The expression of several genes that are known to be regu-
lators of epithelial cell migration during normal wound re-
pair [32] was evaluated by qRT-PCR. The first marker
Table 3 Data extrapolated from Viscotek analysis of experiment
concerning the degradation of H-HA, L-HA and H-HA/L-HA
complex in presence of BTH at 24 h. The decrease percentage of
HHA and of LHA analyzed through the software (Δ%HHA> 1000 kDa
and %LHA <200 kDa) were calculated as the (Mw fraction at t0-Mw
fraction t24h/Mw fraction at t0)
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analysed was TGF-β1. As a growth factor that performs
different activities in proliferation and migration, it can also
regulate MMP gene expression [33]. RT-PCR analyses
showed that TGF-β1 was down-regulated at 4 h in cultures
treated with 0.1 % w/v H-HA or 0.1 % w/v H-HA/L-HA
complex, whilst it was not treated with 0.1 % w/v L-HA. In
the presence of either the complex or H-HA, TGF-β1 ex-
pression was increased at 10 h and 16 h and, then, they be-
came comparable to the control in the following 24 h.
With 0.1 % w/v L-HA, TGF-β1 was up-regulated 4-fold
with respect to control at 4 h, but decreased with increas-
ing incubation time, maintaining similar behaviour to other
samples for longer time intervals at 10, 16 and 24 h
(Fig. 4a). The expression of the gelatinases MMP-2 (gelati-
nase A) and MMP-9 (gelatinase B), which are known to be
implicated in regulating epithelial cell migration [34], were
also evaluated. Both presented a bell-shaped expression
trend in all treatments tested. Particularly, in the H-HA/
L-HA complex-treated samples, maximal up-regulation for
MMP-9 was observed after 10 h, while up-regulation of
MMP-2 was postponed to 16 h (Fig. 4b,c). The H-HA- and
L-HA-treated samples had a low MMP-2 expression at the
early stage (4 h), followed by up-regulation (i.e. 10 h, 16 h e
24 h) in all the different treatments (Fig. 4b,c). This is
Fig. 1 a Repair area percentage [as (Areat0 − Area t/Areat0) × 100] for the control and in presence of following stimuli: H-HA, L-HA and of H-HA/L-HA
complex, all at 0.1%w/v; the curves are averages of three different experiments with variations within 5 % of the value. b Comparison of the healing
rates between control and the samples H-HA, L-HA and H-HA/L-HA complex (0.1%w/v). The data represent an average of three repeats; with the terms
repeats, we indicate that samples are collected from threeindependent experiments; data shown are means ± SD; the t student is calculated respect to
the control (*p < 0.005; **p < 0.05)
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consistent with an early cellular response prompted by
insult-driven signalling, leading towards complete repair
within 24 h. The effect was more evident with the 0.1 % w/
v H-HA/L-HA complex, since MMP-2 expression was
16- and 22-fold higher than the control at 10 h and 16 h,
respectively (Fig. 4b). In addition, MMP-13, which de-
grades interstitial collagen I-II and III [35], was increas-
ingly up-regulated from 4 h up to 24 h (Fig. 4d). In
particular, in the H-HA-stimulated cells, MMP-13 was
markedly more expressed, specifically 27-fold vs. the con-
trol, and 15-fold vs. the other samples. Type I collagen
gene expression was down-regulated at 4 h (Fig. 4e); how-
ever, later on, it presented an increment of up to 2-fold
(16 h), with a slight reduction in expression at 24 h. This
reduction was significant only for cells treated with H-HA
solutions (Fig. 4e). With higher H-HA/L-HA complex
concentration, TGF-β1 was down-regulated up to 16 h,
and slightly up-regulated at 24 h (Table 4). Type I collagen
was up-regulated in the presence of 0.1 % w/v H-HA/
L-HA between 10 and 16 h, but only at 16 h with the
higher complex concentration. Type I collagen then
became markedly less expressed at 24 h for both the con-
centrations. This last result was expected in HaCaT cells
in the last stage of the reparative process.
Zymography and enzymatic activity
Zymography is a reliable and sensitive method to study
proteolitic activity of MMPs. Our results showed the
Fig. 2 a Repair area percentage [as (Area t0 − Area t/Area t0) × 100 for the control and in presence of following stimuli: H-HA/L-HA complex at 0.1
and 1%w/v; The curves are averages of three indipendent experiments with standard deviation within 5 % of the value. b Comparison of the
healing rates between control and the samples H-HA/L-HA complex 0.1–1%w/v). The data represent an average of three repeats; with the terms
repeats, we indicate that samples are collected from threeindependent experiments; data shown are means ± SD; the t student is calculated
respect to the control(*,**) and HHA/LHA 1 % (§,§§).(*p < 0.05; **p < 0.005; §p < 0.05, §§p < 0.005)
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active form of MMP-2 (gelatinase A 72 kDa) and MMP-
9 (gelatinase B 92kda). After 72 h, the MMP-2, 72 kDa
form and the MMP-9, 92 kDa form, expression are up
regulated in H-HA and H-HA/L-HA complex 1 % w/v,
compared to the control (Fig. 5). Based on these find-
ings, it is evident that H-HA and H-HA/L-HA complex
1 % w/v are efficient in increasing matrix degradation
during wound repair, confirming the role of MMPs in
this process.
The results of the activity assay based on gelatin to
evaluate MMPs in the supernatant of the diverse cell
cultivation, were reported in Table 5. The SEC-HPLC
data, extrapolated, are represented as reduction percentage
of the gelatin amount after 6 h of incubation time. The
substrate degradation slightly increased in presence of
the treatments respect to the control. However all the
stimuli seemed to have a similar behavior in degrading
the gelatin, except for the complexes 1 % that showed
higher Gn reduction equal to 64 %, presumably corre-
sponding to an increase of enzymes amount.
Western blot and immunohistochemical analysis
Western blot analysis revealed a statistical and significant
increase in MMP-13 protein level in the 0.1 % H-HA/
LHA- and 1 % H-HA/LHA-treated samples compared
with control, H-HA- and L-HA-treated ones (Fig. 6).
Qualitative analysis of type I collagen revealed no net dif-
ferences between the control and HA-treated cultures Im-
munohistochemical analyses showed positivity of the cells
to type I collagen, but even using ImageJ analyses quanti-
tative differences cannot be outlined (Figs. 7 and 8).
Discussion
The assessment of robust and efficient in vitro tests may
contribute to diminish pre-clinical studies on animals, a
target that is endorsed by public opinion more and more.
Bearing this in mind, the time-lapse video-microscopy sta-
tion, and, developed assays in particular, may strongly
contribute to simultaneous evaluation of biomolecules
and their analogues. The use of this technique in wound
healing studies is nowadays well established and reports in
the literature are copious [36–39]. This has previously
been used to obtain evidence that hyaluronic acid and its
fragments play a key role in the re-epithelization process
[6]. The present model is based on HaCaT cells because
keratinocytes are known to migrate from the basal layers
of the epidermis to a more superficial one triggering an
array of biochemical events that lead towards the reconsti-
tution of full-thickness skin [40]. All these events are
modulated by HA [28].
Generally we can assess that HA based commercial
products contain higher amounts of hyaluronic with re-
spect to amounts present in physiological conditions (skin
([HA] = 0.5 mg/g wet tissue) because these were thus
diluted in the skin or used for other treatments [28].
At concentrations comparable to commercial products,
high- and low- molecular weight hyaluronans were com-
pared and evaluated, with respect to novel, tailor-made
Fig. 3 a Representative micrographs pictures of HaCaT-HDF scratch assays immediately after the scratches, and in time course of the experiments. Scale
bar, 100 μm. b Repair area percentage [as (Areat0 − Area t/Areat0) × 100] for the control and in presence of following stimuli: H-HA, L-HA H-HA/L-HA
complex at 0.1 and H-HA/L-HA 1%w/v; the curves are averages of three different experiments with standard deviation within 5 % of the value
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complexes constituted from a mixture of these two com-
ponents, for their stability in hyaluronidase attacks and
their effect on scratch-wound healing in in vitro assays.
Interestingly, H-HA/L-HA complexes proved to have bet-
ter resistance to hyaluronidase (BTH). In fact, the lower
molecular weight fraction release was reduced compared
to H-HA samples during enzymatic digestion. This behav-
iour supported the idea that this novel species has a non-
detectable conformation for the enzyme and thus is more
resistant for application in in vivo tissue. Hyaluronidase
seemed to be less active on H-HA present in these hybrid
complexes with respect to H-HA alone. Furthermore, with
regards to L-HA degradation, it must be highlighted that
its enzymatic digestion is generally slower than H-HA
[31] and therefore in our opinion less interesting and in
Fig. 4 Gene expression analysis. The graphs showing normalized fold expression for the genes: transforming growth factor beta 1 (a), metalloproteinase-2
(b), metalloproteinase-9 (c), metalloproteinase-13 (d) and type I collagen (e). Data represent the mean ± SD of six independent experiments. The t student
is evaluated respect to the control (*p< 0.01), (§p< 0.05)
Table 4 Gene expression analysis: Normalized fold increase of
H-HA/L-HA complex 0.1 and 1 % (w/v), relative to gene
expression transforming growth factor beta 1 (TGF-β1) and Type I
collagen (COLIA1) at different time of analysis. Data represent the
mean ± SD of three independent experiments
TGF-β1 COLIA1
H-HA/L-HA complex (% w/v) 0.1 1 0.1 1
4h ↓↓ ↓ ~ =
10 h ↑ ↓ ↑ ↓
16 h ↑ ↓ ↑ ↑↑
24 h = = = ↓
Legend: = as the control, ↑ 1.2–5 fold vs control, ↑↑ 5.2–10 fold vs control, ↑↑↑
>10 fold vs control, ↓ 0.1–0.7, ~ 0.8–0.9 fold vs control, ↓↓ < 0.1 fold vs control
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our results, because degradation is inexistent when L-HA
chains were entrapped in the hybrid complexes. However
this result is in accordance with the lower activity of BTH
on smaller HA chains (e.g. in the conditions used in this
work (0.5 U/ml) e are not able to degrade LHA <100KDa).
We found that presence of H-HA and L-HA forms im-
prove the reparative process, shortening the closure time
of the scratch. The reparative rate depended upon both
HA treatments used and the time elapsed. In the first few
hours (0–6 h) of healing, L-HA (90 kDa) was more effect-
ive than either H-HA or the 0-1 % H-HA/L-HA complex
and stimulated TGF-β1 gene expression. Recent literature
asserts that smaller hyaluronan molecules (usually with an
average molecular weight ranging from 5 to 20 kDa) are
often promoters of early inflammatory responses, which
activate signalling cascades to prompt cell migration and
proliferation towards repair of a lysed area [41].
In spite of the great difference in molecular weight, in
the medium time range (6–12 h), H-HA- and L-HA-
treated cultures displayed a similar repair trend. This
outcome could probably be attributed to the degradation
kinetics of H-HA, which is faster than that of L-HA [31].
Moreover, H-HA/L-HA complexes acted as slow release
systems, freeing L-HA earlier than H-HA, and thus
prompting regeneration later on. With these complexes,
scratch closure was completed within 18 h, one-fourth of
the time needed for control cultures. Therefore, it can be
argued that the combined effect of high- and low-
molecular weight HA is fundamental for tissue repair. In
particular, a slow release of L-HA at the beginning of incu-
bation probably mimics the effect of slight inflammatory
stimulus and may activate the biosynthesis machinery to-
wards healing. This last phenomenon has been observed
in vivo for H-HA and L-HA at the injury site [7–9]. These
results were also corroborated by a statistically significant
increase in the closure rate at the 6–12 h interval in the
presence of H-HA/L-HA complex.
In addition, co-culture with human dermal fibroblast
and keratinocytes [42] was accomplished in order to better
mimic the actual in vivo situation and confirmed the best
beneficial effect of complexes with respect to LHA, but
even of HHA alone. Reparation occurred in a shorter
time, with respect to keratinocyte monolayer probably due
to the synergic effect of two different cellular populations,
even if the curves showed similar trends to the ones ob-
tained for single culture scratch monolayer.
Another interesting feature is the lower viscosity attained
through complex formation, that does not occur when L-
HA and H-HA are mixed after being autoclaved. In fact,
generally, a viscous hydrogel may hamper cell migration.
Surprising H-HA/L-HA complex behaviour permitted the
use of a 1 % w/v H-HA/L-HA complex gel, which en-
hanced the bio-revitalizing effect. Although drop in viscos-
ity was at least 10-fold of H-HA/L-HA with respect to the
same H-HA amount, keratinocyte migration was initially
hampered at 1%w/v concentration, as showed by the lower
closure rate 0–6 h (Fig. 2). We can speculate that hyal-
uronidases produced by the cells degraded H-HA in this
specific time frame thus decreasing viscosity. This bio-
catalytic process leads to a great amount of hyaluronic
fragments in the solution, accelerating the future reparative
action (Fig. 2) [10, 14, 15, 17, 31].
In order to support the macroscopic and morphological
results obtained through time-lapse experiments, we car-
ried out molecular analysis of markers involved in the re-
epithelization process of keratinocytes immediately after
injury. The aim was to evaluate modulation of cellular re-
pair mechanisms when stimulated with biologically active
polymers like hyaluronan and the novel derived complex.
TGF-β1 is among the growth factors that have a positive
influence on re-epithelialization [43]. It is expressed in
Fig. 5 Gelatin zymography showing the activity of 62 kDa MMP-2 and
92 kDa MMP-9 presents in culture medium samples, CTR (untreated
cells), H-HA 0.1 % (w/V) (1400 kDa), L-HA 0.1 % (w/V) (100 kDa), H-HA/
L-HA complex 0.1 % (w/V) and H-HA/L-HA complex 1 % (w/V)
Table 5 MMPs enzymatic assay of cell medium un-treated (CTR)
and treated (H-HA0.1 %, L-HA0.1 %, H-HA/L-HA 0.1 % and 1 %) after
24 of incubation with a scratched HaCat monolayer. The assay was
performed for 6 h under stirring at 37 °C. The reduction percentage
was calculated as [(Gnt0- Gnt6h)/Gnt0]*100 where Gnt0 is gelatin
amount at initial time and Gnt6h is gelatin amount after 6 h
incubation time
Sample Reduction percentage (%)
Gn + cell medium(CTR) 50,9
Gn + cell medium(H-HA 0,1 %) 57,6
Gn + cell medium(L-HA 0,1 %) 56,9
Gn + cell medium(H-HA/L-HA 0,1 %) 59,8
Gn + cell medium(H-HA/L-HA 1 %) 64,4
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epidermal keratinocytes and increases during cutaneous
wound healing, contributing to the regulation of motility
and stimulating gene expression of ECM components,
MMPs and integrins [44, 45]. Initially, TGF-β1 was
down-regulated in H-HA/L-HA-complex treated sam-
ples (Fig. 4). Successively, gene expression was similar
for both H-HA and the complexes, finally resembling
control expression level at 24 h. Instead, cells treated
with L-HA expressed high levels of TGF-β1 already at
4 h being between 4 and 2 fold higher that the control
up to 16 h incubation. TGF-β1 overexpression could be
responsible for the slight inflammatory response necessary
in the recruitment of MMPs [26]. Different patterns of
MMPs expression during the repair phase have been re-
ported in in vitro models of HaCaT monolayers [46]. In
our study, we found an up-regulation of MMP-2 and -9,
especially between 4 and 16 h, when the fastest repair
rate was observed. We hypothesize that the lowering in
viscosity caused by complex formation modified shear
forces and attrition around the cells, permitting faster
cellular migration.
In addition, zymography results confirmed that gelati-
nases, besides the higher RNA expression, are produced
and biologically active. Quantitative differences could not
be evidenced due tho the technique itself. Therefore a
quantitative SEC-HPLC based assay was assessed and Gn
degradation was slightly superior in all the treated sam-
ples, the highest conversion been observed with H-HA/
L-HA complex 1 %. The increases of the MMP2 and 9
expression in presence of treatments, and specifically
with complexes was closely correlated with the increase
of reparation rate.
To further investigate the involvement of the ECM in
wound healing, we examined the expression of MMP-13.
MMP-13 known to be expressed in immortalized human
epidermal keratinocytes [45]. We found progressive up-
regulation of MMP-13 mRNA up to 24 h. It is evident
that cells cannot migrate through native type I collagen
without degrading it, first by the action of MMP-1 and
then by that of MMP-13 [45]. According to Hattori and
collaborators [34], MMP-13 expression is higher in the
early phase of wound repair for murine models. Conversely,
we showed different gene behaviour in our human,
transformed keratinocytes [45]. The presence of a higher
MMP-13 expression was also supported by Western blot-
ting analysis, suggesting enhanced degradation on ECM
(an event required for repair). MMP-13 gene expression
could be associated with its preferential substrate: type I
collagen synthesis [46]. Regulation of collagen synthesis
and its deposition control scar tissue formation. We found
up-regulation over time of type I collagen, with a slight re-
duction at 24 h in all treatments. This could be consistent
with collagen synthesis occurring at lower rates in later
phases of wound regeneration, that is a necessary event
for remodelling [47]. We assume that the gradual repair
and re-building of cell–cell connections prompts collagen
Fig. 6 a Representative western blot analysis of metalloproteinase-13 (MMP-13) protein and α-tubulin housekeeping protein levels in the HaCat scratched
cells at 16 h after scratch and different stimuli. b Western blot band densitometry: the histograms indicate the percentage variations in MMP-13 protein
levels in the control and in treated cells compared to the un-treated cells (CTR). Replicates on each cell extract were run two different western blots. Data
shown are means ± SD; the t student is calculated respect to the control and H-HA/L-HA complex 0.1 and 1 % (**p< 0.01)
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Fig. 7 Immunohistochemical analysis for type I collagen (COLIA1) antigen on HaCat scratched cells at 12 h after treatment with different HA gels
Fig. 8 Quantitative analyses of Immunohistochemical for type I collagen (COLIA1) antigen on HaCat scratched cells at 12 h after treatment with
different HA gels
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synthesis and MMP-13 activation. The main outcome is
higher positivity for type I collagen in HaCaT, in the pres-
ence of 1 % w/v H-HA/L-HA complex, proving once
more a close correlation between matrix formation and
cell proliferation.
As shown in Table 3, when comparing different con-
centrations of the H-HA/L-HA complex, we found a
down-regulation of TGF-β1 in the 0–16 h time range,
confirming a minor inflammatory effect elicited in this
specific model. Concerning the expression trends, the
behaviour of COL1A1 in the presence of both H-HA/
L-HA complexes was similar. The difference in gene ex-
pression between the two stimuli was detectable within
10–16 h. Results were also supported by wound-closure
data in Fig. 3 demonstrating inverted reparative curves
at around 14–15 h. Generally lower expression level of
COL1A1 in HaCat rather than other cells (e.g. fibroblasts)
was due to the different embryonic origin (ectodermal and
mesodermal origin). The down-regulation of COL1A1 in
the presence of 1 % H-HA/L-HA complex at 24 h can be
probably ascribed to a general higher reparative rate that
leads to earlier complete wound closure.
Overall, the empirical and qualitative evaluation of in
vitro wound repair was corroborated by quantitative
evaluation of TLVM devices and software, demonstrating
the effectiveness of the assay. In our study, we did not ob-
serve any persistent inflammatory effect of the 90 kDa L-
HA used, suggesting that controversial data in the
literature should be strictly attributed to short HA frag-
ments [7, 18]. Interestingly, H-HA/L-HA-complexes im-
proved sole H-HA performance. The fact that TGF-β1
expression modulation was almost four times less for the
complexes than for L-HA is very important, proving the
entanglement of short chain with longer ones. Based on
hydrogen bonding, this bridging looses small chains over
time, releasing them to trigger the biochemical arrow
towards the repair target.
Finally, the lower viscosity of the complexes permits
delivery of a higher HA amount to the injury site, has-
tening the repair process.
Conclusions
The concurrent analyses of TLVM and gene expression can
contribute to extricate complicated cellular phenomenon
and to evaluate the action of diverse biomolecules with the
use of in vitro models. In this study, L-HA proved not to be
toxic/inflammatory, and therefore permitted wound closure
similarly to the well-known bioactive H-HA. Novel hybrid
complexes formed by H-HA and L-HA performed better
than HA alone, both at high or low concentrations. Com-
plexes also showed better stability of long chains HA to
hyaluronidases attack, presumably prolonging their half-
lives in vivo. L-HA accelerates wound repair at an earlier
stage, while H-HA has no short-term effect, probably due
to its initial higher viscosity. The outcomes of this study
may be the pillars for further in vivo studies to promote
HA hybrid complex use in innovative medical devices for
tissue regeneration.
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